EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary microRNA Profiles Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia: An Exploratory Two-Cohort Small-RNA Sequencing Study

Marco Ragusa, Michele Stella, Cinzia Di Pietro, Cristina Barbagallo, Domenico Scionti, Maria Carmela Di Rosa, Giovanni Carapezza, Donato Gemmati, Veronica Tisato, Elisabetta D’Aversa, Antonio Marin Romero, Mavys Tabraue-Chavez und 3 weitere

Cells · 16.11.2026 · 15 (22) · 2092

DOI: 10.3390/cells15222092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 16.11.2026. Verfasst von Marco Ragusa und 14 weiteren Autor:innen. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary microRNAs (miRNAs) are candidate non-invasive markers for distinguishing prostate cancer (PCa) from benign prostatic hyperplasia (BPH), but differences found in a single cohort often fail to recur in another. In this exploratory study, we sequenced small RNA from whole urine of two independently recruited cohorts of 7 and 25 subjects and examined how consistently PCa-versus-BPH differences recurred across them, using molecule counts that retain the orientation of each sequencing read. Fold changes of the miRNAs measured in both cohorts were broadly correlated, and 25 miRNAs differed significantly in both with the same direction; the largest decreases in PCa involved miRNAs enriched in leukocytes. An eight-miRNA score defined in the first cohort separated PCa from BPH in the second and discriminated better than serum prostate-specific antigen in a small subset with available values, an encouraging result to be confirmed in larger cohorts; these results are consistent with the original quantification and remain so after accounting for recruitment centre. Directions agreed only partly with public urine and serum data and were largely opposite to tumour tissue, consistent with whole urine reflecting several cellular sources. These hypothesis-generating findings require confirmation in larger, prospectively recruited cohorts with orthogonal assays.

Zitieren

APA

Ragusa, M., Stella, M., Pietro, C. D., Barbagallo, C., Scionti, D., Rosa, M. C. D., Carapezza, G., Gemmati, D., Tisato, V., D’Aversa, E., Romero, A. M., Tabraue-Chavez, M., Sanchez-Martin, R. M., Diaz-Mochon, J. J., & Pernagallo, S. (2026). Urinary microRNA Profiles Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia: An Exploratory Two-Cohort Small-RNA Sequencing Study. Cells, 15(22), 2092. https://doi.org/10.3390/cells15222092

Vancouver

Ragusa M, Stella M, Pietro CD, Barbagallo C, Scionti D, Rosa MCD, et al. Urinary microRNA Profiles Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia: An Exploratory Two-Cohort Small-RNA Sequencing Study. Cells. 2026;15(22):2092. doi:10.3390/cells15222092

BibTeX
@article{Ragusa2026,
  author = {Ragusa, Marco and Stella, Michele and Pietro, Cinzia Di and Barbagallo, Cristina and Scionti, Domenico and Rosa, Maria Carmela Di and Carapezza, Giovanni and Gemmati, Donato and Tisato, Veronica and D’Aversa, Elisabetta and Romero, Antonio Marin and Tabraue-Chavez, Mavys and Sanchez-Martin, Rosario Maria and Diaz-Mochon, Juan Jose and Pernagallo, Salvatore},
  title = {Urinary microRNA Profiles Distinguishing Prostate Cancer from Benign Prostatic Hyperplasia: An Exploratory Two-Cohort Small-RNA Sequencing Study},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {2092},
  doi = {10.3390/cells15222092}
}
Kostenlos starten →